ProCE Banner Activity

MM22: Current Evidence on Immunomodulatory Therapies to Treat COVID-19

Multimedia
In this presentation, Jens D. Lundgren, MD, DMSc, discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19.

Released: October 16, 2020

Expiration: October 15, 2021

Share

Faculty

Jens D. Lundgren

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grant provided by

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Jens D. Lundgren, MD, DMSc, has no relevant conflicts of interest to report.